Evidence map›Paper›PMID 39948239›Full record

ArticleBritish journal of cancer2025

Treating tobacco dependency in cancer care: essential, cost-effective, and feasible, yet overlooked.

Mahdi Sheikh, Matthew Evison

Abstract readEditorial
In one paragraph

Article in British journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mahdi SheikhGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC - WHO), Lyon, France.
Matthew EvisonLung Cancer & Thoracic Surgery Directorate, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK. m.evison@nhs.net.ORCID http://orcid.org/0000-0003-4066-5253

Funding

World Health Organization 001
6 · The paper itself

Abstract

Treating tobacco dependency in patients diagnosed with cancer delivers substantial benefits; improved overall survival, reduced risk of disease recurrence, less treatment-related adverse events and improved quality of life. This study by Mullen et al provides important data on cost-savings and return on investment from embedding tobacco dependency treatment within cancer care and is a call to arms for equitable access to these treatments for all patients diagnosed with cancer.

Indexed as

NeoplasmsTobacco Use DisorderCost-Benefit AnalysisHumansQuality of LifeSmoking Cessation

Identifiers

PMID39948239
PMCPMC11961718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.